Home › Triple-Negative Breast Cancer › Arkansas
Triple-Negative Breast Cancer clinical trials in Arkansas
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in Arkansas.
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of Arkansas Medical School, Little Rock
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Sep 28, 2026 · NCT06586957A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- Local Institution - 0303, Hot Springs
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06926868Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - FTS, Fort Smith
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT07327489From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.